Cardiovascular involvement in rheumatoid arthritis

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Rheumatoid arthritis (RA) is linked to increased cardiovascular (CV) disease morbidity and mortality.
• Atherosclerosis (ATS) is a major contributor to excess CV disease in RA patients.
• The pathogenesis of CV disease in RA involves complex interactions between traditional and novel CV risk factors, RA treatments, and the inflammatory disease process.

Purpose of the Study:

• To explore the multifaceted factors contributing to cardiovascular disease in rheumatoid arthritis.
• To investigate the role of chronic inflammation and immune dysregulation in RA-associated atherosclerosis.
• To understand the impact of endothelial dysfunction as an early marker in RA patients.

Main Methods:

• Review of existing literature on cardiovascular disease in rheumatoid arthritis.
• Analysis of the interplay between RA disease activity, inflammation, and atherosclerosis development.
• Examination of endothelial dysfunction as a consequence of chronic inflammation in RA.

Main Results:

• Chronic inflammation and immune dysregulation in RA are associated with endothelial dysfunction.
• RA disease severity influences CV risk factors and drug prescribing, complicating direct assessment of inflammation's impact.
• Atherosclerosis pathogenesis in RA is multifactorial, involving inflammatory processes and immune responses.

Conclusions:

• The inflammatory disease process in rheumatoid arthritis plays a significant role in the development of atherosclerosis and cardiovascular disease.
• Endothelial dysfunction is a key mechanism linking RA inflammation to cardiovascular risk.
• Further research is needed to disentangle the specific contributions of inflammation versus other factors in RA-related cardiovascular complications.